Pharmaceutical Regulatory Affairs Publications
Pharmaceutical Regulatory Affairs:
Open Access provides the rapid Bi-annually publication of
articles in all areas related to Regulatory Guidelines, Regulatory compliance, Medical devices regulations, Regulatory Affairs, Pharmaceutics, Pharmaceutical formulation, Biopharmaceutics, Drug development, Intellectual property rights, Drug discovery, Pharmaceutical care,
Drug Delivery System, Pharmaceutical Sciences, Pharmaceutical Marketing, Clinical Trials, Pharmacovigilance. Pharmaceutical Regulatory Affairs:
Open Access will support authors by posting the published version of
articles by NIH grant-holders and European or UK-based biomedical or life sciences grant holders to PubMed Central immediately after publication. Pharmaceutical Regulatory Affairs:
Open Access provides free access to all the published materials to its users/readers. However, the publisher does not get any institutional or organizational support to meet its publication and archiving expenses. The basic article processing fee or manuscript handling cost is as per the price mentioned above on the other hand it may vary based on the extensive editing, colored effects, complex equations, extra elongation of no. of pages of the article, etc. A research article is a primary source. It reports the original study performed by the authors. A Results and Discussion section describes the outcomes of the data analysis. Charts and graphs illustrating the results are typically included followed by conclusion and References.
High Impact List of Articles
Relevant Topics in General Science